New mRNA vaccine could reduce the recurrence and spread of skin cancer

Feed excerpt — reported by NPR Politics

Merck and Moderna announced a successful late-stage trial for a melanoma vaccine. NPR's Leila Fadel talks to Dr. Robert Vonderheide of Penn Medicine and the American Association for Cancer Research.

MAP records observable characteristics of the original article (publisher, author, date, references, framing cues). MAP does not verify the article’s claims or score it. Read the full original story at NPR Politics →

View MAP Context →